Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Date:5/18/2010

lts of the Phase III study regarding Endu's safety and efficacy," Mr. Ren continued. "Simcere's strategic cardiovascular portfolio also continues to grow with our recently launched cholesterol lowering drug Rosuvastatin and hypertension drug Levamlodipine both performing well. We are confident that these developments should help position Simcere for growth over the mid-to-long-term."

2010 First Quarter Financial Results

Total revenue for the first quarter of 2010 was RMB458.7 million (US$67.2 million), compared to RMB442.5 million for the same period in 2009, representing year-over-year growth of 3.7%.

Revenue from edaravone injection products under the brand names Bicun and Yidasheng increased by 8.5% to RMB173.2 million (US$25.4 million) for the first quarter of 2010 from RMB159.6 million for the same period in 2009. Sales of edaravone injection products constituted 37.8% of the Company's product revenue for the first quarter of 2010.

Revenue from Endu, the Company's patented anti-cancer biotech product, increased by 2.3% to RMB37.4 million (US$5.5 million) in the first quarter of 2010 from RMB36.5 million for the same period in 2009. Sales of Endu constituted 8.2% of the Company's product revenue for the first quarter of 2010.

Revenue from Sinofuan, a 5-FU sustained release implant for the treatment of cancer, increased by 1.0% to RMB25.3 million (US$3.7 million) for the first quarter of 2010 from RMB25.1 million for the same
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Simceres Diosmectite API Passes EU-GMP Inspection
2. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
3. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
4. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
7. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
8. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
9. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
11. Isis Pharmaceuticals to Discuss Its Cancer Franchise in a Conference Call on Wednesday, May 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... N.C. , July 2, 2015 ... employees to capture critical product and market insights ... many benefits to employee-based studies, it is essential ... their own internal employees to capture critical business-related ... by benchmarking firm, Best Practices, LLC, most benchmarked ...
(Date:7/2/2015)... 2015  Before you head outdoors with your family to ... safe and healthy. Take steps to protect yourself from the ... Protect Your Skin From the Sun ... your risk of skin cancer. To protect your skin from ... especially during midday hours. Wear a hat with a wide ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the addition ... Application - Forecast to 2020" report to their offering. ... Billion in 2020 from an estimated $7.1 Billion in 2015, growing ... by North America , followed by ... the World (RoW). The cancer diagnostics market in Asia ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2
... /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), through ... Ltd (Yinfa), announces it has appointed Loeb & Loeb ... acquisition initiative. Andrew Ross, a partner with New York-based ... the Mergers and Acquisition Practice Group and known for ...
... Dec. 27, 2011 BNA Books , a division ... announces the publication of the 2011 Supplement ... , discussing domestic and international developments in pharmaceutical patent law. ... Pharmaceutical Patent Law, Second Edition  tracks legal developments within the ...
Cached Medicine Technology:China Health Resource Appoints USA Acquisition Counsel 2China Health Resource Appoints USA Acquisition Counsel 3BNA Books Announces the Publication of the 2011 Supplement to "Pharmaceutical Patent Law, Second Edition" 2BNA Books Announces the Publication of the 2011 Supplement to "Pharmaceutical Patent Law, Second Edition" 3
(Date:7/4/2015)... ... ... gains access to someone’s email account, it can lead to all sorts of trouble, both ... issued a scam alert about a social engineering scam which cons a target into ... the hacker. All they have to do is click for a password reset and ...
(Date:7/3/2015)... ... ... Bank will hopefully be getting a large donation of canned food items at the ... are making it their mission to collect as many canned items as possible. Donations do ... public as well. As part of the canned food drive, these local chiropractors will be ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... Friend opened registration for a new SEO training system called "Page One ... for organic traffic generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's ...
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, ... retained to lead a national president recruitment for Regional Care, Inc. ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... Resort and Casino Ranks Highest in Satisfaction With ... the Casino Experience in Inaugural Study, ... 85,percent -- of gaming customers at Indian casinos in Southern ... casinos,according to the J.D. Power and Associates 2008 Southern California ...
... Virginia Commonwealth University and VCU Massey Cancer Center ... associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that ... harming healthy ones, a discovery that could lead ... , The findings may provide a method ...
... autistic child has,filed a class action lawsuit against Blue Cross ... Judge Sean Cox in Federal Court. Mr. Chris,Johns alleges that ... care. The suit alleges that Blue Cross is required to,provide ... but that it,has not done so in bad faith and ...
... KIBBUTZ SHAMIR, Israel, July 1 Shamir Optical,Industry ... of innovative,products and technology to the lens market, announced ... 2008, pursuant to which it has,purchased 49% of Altra ... transaction, Shamir held 51% of the share,capital of Altra, ...
... Brooks forms alliance with Home Care Advantage, ... Home Care Advantage, a Jacksonville-based home,health care agency ... market and,more than $10 million in revenue. Home ... health agency in Jacksonville. Brooks, the largest,rehabilitation provider ...
... 1 Repligen Corporation,(Nasdaq: RGEN ) announced today ... its Board of Directors. Dr. Goldberg is currently a ... a renowned scientist noted in,particular for elucidating the structure ... which most proteins are destroyed in,cells. In addition, he ...
Cached Medicine News:Health News:J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment 2Health News:J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment 3Health News:J.D. Power and Associates Reports: A Vast Majority of Southern California Indian Gaming Casino Customers Express Desire for a Smoke-Free Environment 4Health News:Discovery of gene mechanism could bring about new ways to treat metastatic cancer 2Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 2Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 3Health News:Jacksonville's Largest Rehab Provider Acquires Largest Home Health Agency 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 3
... AS100 Analyzer is designed ... regardless of the sample ... launched in December 2004, ... in May 2005. Assays ...
Rapid test for the presumptive identification of Candida albicans from culture media....
... you can test for Candida albicans ... Hardy AlbiQuicktm utilizes two enzyme color ... that's easy to read. AlbiQuicktm is ... two reation wells. Incubation time is ...
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
Medicine Products: